// App-Quantinova.ai

2941 : Increased expression of ABCB1/MDR1 could be associated with alectinib resistance in ALK-rearranged lung cancer cells

Researchers

Presenter

  • Takahiro Tsuji

Principal Investigators

  • Hiroaki Ozasa

  • Yuichi Sakamori

  • Takashi Nomizo

  • Yoshitaka Yagi

  • Hiroki Nagai

  • Young Hak Kim

  • Michiaki Mishima

Medical Centers

  • Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lymphomas

  • Solid malignancies

Biomarkers

  • ATP Binding Cassette Transporter B1

Drug/Treatment

  • Alectinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved